(Q24234400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

meta-analysis

0 references

title

Probiotics for maintenance of remission in ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Khimara Naidoo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Andrew O Fagbemi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Adrian G Thomas

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Anthony K Akobeng

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

7 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

CD007443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Medical therapy for ulcerative colitis 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Accuracy of data in abstracts of published research articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Variable response to probiotics in two models of experimental colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

A simple clinical colitis activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

7 January 2021

Probiotic therapy fails to improve gut permeability in a hapten model of colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

7 January 2021

Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

7 January 2021

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

7 January 2021

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007443.PUB2

7 January 2021

10.1002/14651858.CD007443.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161412%20AND%20SRC:MED&resulttype=core&format=json